A.R.T. Advisors’s Five Prime Therapeutics, Inc. FPRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-18,790
| Closed | -$86K | – | 1224 |
|
|
2019
Q4 | $86K | Sell |
18,790
-118,779
| -86% | -$544K | ﹤0.01% | 1225 |
|
|
2019
Q3 | $533K | Buy |
137,569
+33,000
| +32% | +$128K | 0.03% | 832 |
|
|
2019
Q2 | $631K | Buy |
+104,569
| New | +$631K | 0.04% | 652 |
|
|
2018
Q4 | – | Sell |
-28,259
| Closed | -$393K | – | 1809 |
|
|
2018
Q3 | $393K | Sell |
28,259
-22,110
| -44% | -$307K | 0.02% | 947 |
|
|
2018
Q2 | $796K | Sell |
50,369
-108,400
| -68% | -$1.71M | 0.03% | 737 |
|
|
2018
Q1 | $2.73M | Buy |
158,769
+6,500
| +4% | +$112K | 0.11% | 270 |
|
|
2017
Q4 | $3.34M | Buy |
152,269
+127,295
| +510% | +$2.79M | 0.15% | 193 |
|
|
2017
Q3 | $1.02M | Buy |
+24,974
| New | +$1.02M | 0.05% | 523 |
|
|
2015
Q1 | – | Sell |
-20,385
| Closed | -$550K | – | 1796 |
|
|
2014
Q4 | $550K | Buy |
+20,385
| New | +$550K | 0.02% | 896 |
|